Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1980 3
1981 1
1983 1
1984 3
1985 4
1986 2
1987 5
1988 3
1989 3
1990 4
1991 11
1992 12
1993 12
1994 13
1995 11
1996 6
1997 7
1998 4
1999 6
2000 2
2001 1
2002 1
2003 6
2004 6
2005 6
2006 5
2007 9
2008 5
2009 17
2010 16
2011 9
2012 20
2013 15
2014 14
2015 8
2016 11
2017 10
2018 5
2019 8
2020 14
2021 12
2022 9
2023 14
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

324 results

Results by year

Filters applied: . Clear all
Page 1
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα.
Hanan EJ, Braun MG, Heald RA, MacLeod C, Chan C, Clausen S, Edgar KA, Eigenbrot C, Elliott R, Endres N, Friedman LS, Gogol E, Gu XH, Thibodeau RH, Jackson PS, Kiefer JR, Knight JD, Nannini M, Narukulla R, Pace A, Pang J, Purkey HE, Salphati L, Sampath D, Schmidt S, Sideris S, Song K, Sujatha-Bhaskar S, Ultsch M, Wallweber H, Xin J, Yeap S, Young A, Zhong Y, Staben ST. Hanan EJ, et al. Among authors: friedman ls. J Med Chem. 2022 Dec 22;65(24):16589-16621. doi: 10.1021/acs.jmedchem.2c01422. Epub 2022 Dec 1. J Med Chem. 2022. PMID: 36455032
RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy.
Song KW, Edgar KA, Hanan EJ, Hafner M, Oeh J, Merchant M, Sampath D, Nannini MA, Hong R, Phu L, Forrest WF, Stawiski E, Schmidt S, Endres N, Guan J, Wallin JJ, Cheong J, Plise EG, Lewis Phillips GD, Salphati L, Heffron TP, Olivero AG, Malek S, Staben ST, Kirkpatrick DS, Dey A, Friedman LS. Song KW, et al. Among authors: friedman ls. Cancer Discov. 2022 Jan;12(1):204-219. doi: 10.1158/2159-8290.CD-21-0072. Epub 2021 Sep 20. Cancer Discov. 2022. PMID: 34544753 Free PMC article.
Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility.
Guan J, Zhou W, Hafner M, Blake RA, Chalouni C, Chen IP, De Bruyn T, Giltnane JM, Hartman SJ, Heidersbach A, Houtman R, Ingalla E, Kategaya L, Kleinheinz T, Li J, Martin SE, Modrusan Z, Nannini M, Oeh J, Ubhayakar S, Wang X, Wertz IE, Young A, Yu M, Sampath D, Hager JH, Friedman LS, Daemen A, Metcalfe C. Guan J, et al. Among authors: friedman ls. Cell. 2019 Aug 8;178(4):949-963.e18. doi: 10.1016/j.cell.2019.06.026. Epub 2019 Jul 25. Cell. 2019. PMID: 31353221 Free article.
Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors.
Vasan N, Razavi P, Johnson JL, Shao H, Shah H, Antoine A, Ladewig E, Gorelick A, Lin TY, Toska E, Xu G, Kazmi A, Chang MT, Taylor BS, Dickler MN, Jhaveri K, Chandarlapaty S, Rabadan R, Reznik E, Smith ML, Sebra R, Schimmoller F, Wilson TR, Friedman LS, Cantley LC, Scaltriti M, Baselga J. Vasan N, et al. Among authors: friedman ls. Science. 2019 Nov 8;366(6466):714-723. doi: 10.1126/science.aaw9032. Science. 2019. PMID: 31699932 Free PMC article.
Delta agent hepatitis.
Chatzinoff M, Friedman LS. Chatzinoff M, et al. Among authors: friedman ls. Infect Dis Clin North Am. 1987 Sep;1(3):529-45. Infect Dis Clin North Am. 1987. PMID: 3332883 Review.
Introduction of Clinical Practice Update Committee Articles.
Friedman LS, Inadomi JM, Kalloo AM, Katzka DA, Kim LS, Koch J, Lieberman D, Lichtenstein GR, Lim JK, Pandolfino JE, Shin AS, Siedler MR. Friedman LS, et al. Clin Gastroenterol Hepatol. 2017 Jan;15(1):4. doi: 10.1016/j.cgh.2016.11.011. Clin Gastroenterol Hepatol. 2017. PMID: 27979048 No abstract available.
Isolated Hepatitis B Core Antibody.
Martin P, Friedman LS. Martin P, et al. Among authors: friedman ls. Gastro Hep Adv. 2023 Mar 15;2(6):746. doi: 10.1016/j.gastha.2023.03.012. eCollection 2023. Gastro Hep Adv. 2023. PMID: 39130116 Free PMC article. No abstract available.
Teaching in the office.
Friedman LS. Friedman LS. Dig Dis Sci. 2015 Apr;60(4):832-4. doi: 10.1007/s10620-015-3623-y. Dig Dis Sci. 2015. PMID: 25764499 No abstract available.
Treatment of Dyslipidemia in Common Liver Diseases.
Speliotes EK, Balakrishnan M, Friedman LS, Corey KE. Speliotes EK, et al. Among authors: friedman ls. Clin Gastroenterol Hepatol. 2018 Aug;16(8):1189-1196. doi: 10.1016/j.cgh.2018.04.023. Epub 2018 Apr 21. Clin Gastroenterol Hepatol. 2018. PMID: 29684459 Free PMC article. Review. No abstract available.
Systemic causes of cholestasis.
Delemos AS, Friedman LS. Delemos AS, et al. Among authors: friedman ls. Clin Liver Dis. 2013 May;17(2):301-17. doi: 10.1016/j.cld.2012.11.001. Epub 2013 Jan 26. Clin Liver Dis. 2013. PMID: 23540504 Free PMC article. Review.
324 results